Ruida Health Industry engages in the development of innovative drugs and innovative treatment technologies. The company has established a research and development team of more than 200 people, including more than ten cooperating academicians, winners of the National Outstanding Youth Fund, and winners of important national projects. Ruida Health has deployed the biopharmaceutical industry chain and established industrial entities in Hefei, Huainan, and Hainan. As the R&D base in Hefei High-tech Zone, Ritar Health and the University of Science and Technology of China established the "University of Science and Technology of China-Rida Joint Life Research Center", and the Institute of Advanced Research of the University of Science and Technology of China established the "University of Science and Technology of China-Enkai Immunotherapy Technology Joint Laboratory", "University of Science and Technology of China-Rida Immunotherapy" Joint Laboratory", set up "Anhui Provincial Academician Workstation" and "Anhui Provincial Immunotherapy Engineering Laboratory" to continuously deliver innovative results for the company and quickly realize the transformation of scientific and technological achievements. Sailepu Pharmaceuticals is the production base of APIs. Hainan Boao Ruida Medicel International Medical Center, as a clinical transformation base, relies on the advantages of national policies to carry out clinical applications and provide clinical trial data for the company's new products.